Leaflet ELOSALIC 1mg / 5mg / g ointment


Indicated for: asthma; chronic obstructive pulmonary disease

Route of administration: cutaneous

Substance: mometasone + salicylic acid (glucocorticoid + keratolytic)

ATC: D07XC03 (Dermatologicals | Corticosteroids, other combinations | Corticosteroids, potent, other combinations)

Mometasone in combination with salicylic acid is a treatment used for inflammatory and hyperkeratotic skin conditions, such as psoriasis. Mometasone is a corticosteroid that reduces inflammation, itching, and redness, while salicylic acid acts as a keratolytic, helping to remove thickened skin layers and enhance the absorption of mometasone.

This combination is effective in relieving psoriasis symptoms, such as thick plaques, scales, and inflammation. It is applied to the affected areas of the skin but should not be used on open wounds or healthy skin.

Side effects may include local irritation, dryness, burning sensation, or, more rarely, skin thinning with prolonged use. It is important to use the treatment as directed by a doctor and to limit the duration to avoid systemic side effects.

This combination is intended for external use only and should not be used without a specialist's recommendation.

General data about ELOSALIC 1mg / 5mg / g

  • Substance: mometasone + salicylic acid
  • Date of last drug list: 01-01-2019
  • Commercial code: W57218002
  • Concentration: 1mg / 5mg / g
  • Pharmaceutical form: ointment
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).